Paul Fiedler, MD
Anatomic Pathology & Clinical Pathology · New Haven, CTNPI 1245348044
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $663 and has fallen 92.3% since, to $51 in 2025.
Across 46 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$111
- E.r. Squibb & Sons, L.L.C.$84
- Seagen Inc.$73
- AstraZeneca$67
- Exelixis Inc.$55
- Bayer$55
- plus $456 from 15 others
What the payments were for
- Food & beverage$86196%
- Education$404%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 3 | $111 |
| E.r. Squibb & Sons, L.L.C. | 4 | $84 |
| Seagen Inc. | 4 | $73 |
| AstraZeneca(2 entities) | 4 | $67 |
| Exelixis Inc. | 3 | $55 |
| Bayer | 3 | $55 |
| Ipsen Biopharmaceuticals, Inc | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $51 |
| Array Biopharma Inc | 2 | $50 |
| AMAG Pharmaceuticals, Inc. | 2 | $40 |
| Amgen | 2 | $33 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $32 |
| Caris MPI, Inc. | 1 | $31 |
| Johnson & Johnson | 2 | $28 |
| Taiho Oncology, Inc. | 1 | $25 |
| GSK | 1 | $23 |
| Puma Biotechnology, Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $23 |
| Incyte Corporation | 1 | $18 |
| Clovis Oncology, Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
How this compares
$902 in reported general payments places this provider in the 85th percentile of 94 anatomic pathology & clinical pathology providers in Connecticut.
See all anatomic pathology & clinical pathology providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in New Haven
- Kurt SchalperNew Haven$138K
- Marie RobertNew Haven$128K
- Mina XuNew Haven$9K
- Chen LiuNew Haven$9K
- Gilbert MoeckelNew Haven$2K
- Yuanxin LiangNew Haven$2K
- Alexa SiddonNew Haven$2K
- He WangNew Haven$237
- Minhua WangNew Haven$159
- Il Song HahnNew Haven$153
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.